The Orka Two is a behind-the-ear prescription hearing aid released in 2023, priced at $1,899 in the premium tier. In HearAdvisor's lab testing, it earned a SoundGrade of B with a SoundScore of 3.82 out of 5, placing it in the middle of the prescription hearing aid category.
This device demonstrates clear strengths in speech clarity for quiet environments, scoring 0.69 points above the category average—a notable advantage for users who primarily need help in calm settings like one-on-one conversations. Feedback handling is excellent, achieving a perfect 5.0/5 in both fit conditions, meaning users can expect minimal whistling during daily wear. Own-voice comfort also performs above average, suggesting reduced occlusion effects compared to many competitors.
However, the Orka Two shows limitations in noisy environments. Speech-in-noise performance sits just barely above average in combined scores but was notably weak in initial fit testing. This may be a concern for users who frequently navigate restaurants, busy offices, or social gatherings. At this price point, competitors like the Rexton Reach R-Li T80 at Costco ($1,899) deliver substantially higher overall performance with a 4.54 SoundScore.
The Orka Two is best suited for users who prioritize quiet-environment speech clarity, strong feedback control, and features like rechargeable batteries with both iPhone and Android streaming. Those needing robust performance in challenging acoustic environments may want to consider higher-scoring alternatives at similar or lower price points.
